Latest Psoriasis Stories
Results from Phase 2b X-PLORE Study through Week 40 Report Efficacy of Guselkumab across Multiple Dosing Regimens and Compared with Adalimumab DENVER, March 24, 2014 /PRNewswire/ -- New findings
- FEATURE and JUNCTURE data show secukinumab delivered significant skin clearance at week 12(1,2) EAST HANOVER, N.J., March 22, 2014 /PRNewswire/ -- Novartis today announced results
CANTERBURY, England, March 21, 2014 /PRNewswire/ -- - Phase 2b data demonstrates a 60% reduction in pruritus in psoriatic patients treated with
NORTH CHICAGO, Ill., March 20, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA® (adalimumab) as a treatment
Psoriasis Free For Life made by Katy Wilson is a newly updated psoriasis treatment program includes natural and safe remedies for reducing symptoms of psoriasis disease.
Cloud-based training collaboration delivers clinically relevant information anywhere. CONSHOHOCKEN, Pa., March 18, 2014 /PRNewswire/ -- The Group for Research and Assessment of
TriDerma’s Facial Redness Repair™ and Psoriasis Control™ Products are now available at Target stores throughout California.
An Extension Of The Gentle Skin Cleanser You Already Love FORT WORTH, Texas, March 4, 2014 /PRNewswire/ -- Galderma Laboratories, L.P., makers of Cetaphil® products, the #1 dermatologist-recommended
"Right the Wrong of Rosacea" with Awareness, Education and Treatment FT. WORTH, Texas, March 3, 2014 /PRNewswire/ -- Sometimes, red is just wrong.
Proceeds Bring Series B to CHF 44.9 Million ZURICH-SCHLIEREN, Switzerland, Feb.
- Emitting flashes of light; glittering.